Washington University St. Louis School of Medicine: Diabetes Reversed in Mice With Genetically Edited Stem Cells Derived From Patients
April 23, 2020
April 23, 2020
ST. LOUIS, Missouri, April 23 -- The Washington University St. Louis School of Medicine issued the following news release:
Using induced pluripotent stem cells produced from the skin of a patient with a rare, genetic form of insulin-dependent diabetes called Wolfram syndrome, researchers transformed the human stem cells into insulin-producing cells and used the gene-editing tool CRISPR-Cas9 to correct a genetic defect that had caused the syndrome. They then implanted the cells into . . .
Using induced pluripotent stem cells produced from the skin of a patient with a rare, genetic form of insulin-dependent diabetes called Wolfram syndrome, researchers transformed the human stem cells into insulin-producing cells and used the gene-editing tool CRISPR-Cas9 to correct a genetic defect that had caused the syndrome. They then implanted the cells into . . .